DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Awada A, Colomer R, Inoue K. et al.
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.
JAMA oncology 2016;
2: 1557-1564
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.